Delivering mesenchymal stem cells in collagen microsphere carriers to rabbit degenerative disc - Reduced risk of osteophyte formation. by Chow, ST et al.
Title
Delivering mesenchymal stem cells in collagen microsphere
carriers to rabbit degenerative disc - Reduced risk of osteophyte
formation.
Author(s) Li, YY; Diao, HJ; Chik, TK; Chow, ST; An, XM; Leung, VYL;Cheung, KMC; Chan, BP
Citation Tissue Engineering Part A: Tissue Engineering, 2014, v. 20 n. 9-10, p. 1379-1391
Issued Date 2014
URL http://hdl.handle.net/10722/203038
Rights
This is a copy of an article published in the Tissue Engineering
Part A: Tissue Engineering © 2014 copyright Mary Ann Liebert,
Inc.;Tissue Engineering Part A: Tissue Engineering is available
online at: http://www.liebertonline.com.
Delivering Mesenchymal Stem Cells in Collagen
Microsphere Carriers to Rabbit Degenerative Disc:
Reduced Risk of Osteophyte Formation
Yuk Yin Li, PhD,1,* Hua Jia Diao, PhD,1,* Tze Kit Chik, PhD,1 Cin Ting Chow,1 Xiao Meng An, PhD,1
Victor Leung, PhD,2 Kenneth Man Chi Cheung, MD,2 and Barbara Pui Chan, PhD1
Mesenchymal stem cells (MSCs) have the potential to treat early intervertebral disc (IVD) degeneration.
However, during intradiscal injection, the vast majority of cells leaked out even in the presence of hydrogel
carrier. Recent evidence suggests that annulus puncture is associated with cell leakage and contributes to
osteophyte formation, an undesirable side effect. This suggests the significance of developing appropriate
carriers for intradiscal delivery of MSCs. We previously developed a collagen microencapsulation platform,
which entraps MSCs in a solid microsphere consisting of collagen nanofiber meshwork. These solid yet porous
microspheres support MSC attachment, survival, proliferation, migration, differentiation, and matrix re-
modeling. Here we hypothesize that intradiscal injection of MSCs in collagen microspheres will outperform that
of MSCs in saline in terms of better functional outcomes and reduced side effects. Specifically, we induced disc
degeneration in rabbits and then intradiscally injected autologous MSCs, either packaged within collagen
microspheres or directly suspended in saline, into different disc levels. Functional outcomes including hydration
index and disc height were monitored regularly until 6 months. Upon sacrifice, the involved discs were
harvested for histological, biochemical, and biomechanical evaluations. MSCs in collagen microspheres showed
advantage over MSCs in saline in better maintaining the dynamic mechanical behavior but similar performance
in hydration and disc height maintenance and matrix composition. More importantly, upon examination of gross
appearance, radiograph, and histology of IVD, delivering MSCs in collagen microspheres significantly reduced
the risk of osteophyte formation as compared to that in saline. This work demonstrates the significance of using
cell carriers during intradiscal injection of MSCs in treating disc degeneration.
Introduction
The potential of using mesenchymal stem cells(MSCs) to treat intervertebral disc (IVD) degeneration
has been suggested in numerous animal models ranging
from mice to cows.1–24 In general, most if not all in vivo
studies inject MSCs intradiscally in animals with in-
duced disc degeneration. Enhanced matrix accumula-
tion,6,10,11,18,20 differentiation of MSCs into chondrogenic
lineages,6,8,10,18 and improvement in functional outcomes,
such as disc height7,11 and hydration index,11 have been
reported. Despite these encouraging results, the efficacy and
safety of intradiscal injection of MSCs to treat disc degen-
eration have to be critically evaluated before well-designed
clinical trials can be conducted. One long-lasting problem,
which might cause suboptimal functional outcomes and
adverse side effect of MSC-based therapy, is cell leakage.
During intradiscal injection, puncturing through the annulus
into the cavity containing nucleus pulposus (NP) is neces-
sary but the intradiscal pressure25 in the disc would extrude
the NP out. Therefore, the puncturing procedure itself has
been used to induce disc degeneration26 where magnetic
resonance imaging (MRI) signal reduction, disc height re-
duction, and complications, such as herniation and osteo-
phyte formation, are evident. Among the in vivo studies of
MSC-based therapy in disc degeneration, most models inject
cells in saline without a carrier6,8–10,17,18,20 while others in
hydrogel carriers, such as hyaluronic acid,7,21 atelocolla-
gen,11 and fibrin.19 However, backflow of the injected cells
in saline is usually observed immediately after injection.
Previous study reported that < 1% of the labeled cells were
detected in NP immediately after injection and a further
significant reduction of injected cells was noted on day 7
even though a hydrogel carrier was used.7 One primary
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reason is the disc-pressure-induced extrusion of injected
MSCs and the semifluid-like hyaluronic acid hydrogel, which
has a viscosity of around 100 Pa, outside the disc space.7
Recently, undesirable side effect of intradiscal injection of
MSCs, namely, osteophyte formation, has been reported.27
Specifically, injecting allogenic MSCs to degenerative disc in
rabbit resulted in formation of large bony structures called
osteophytes in all animals at 3 months postinjection,27 cor-
roborating with a previous report on osteophyte formation
after MSC injection in healthy disc.14 Most importantly, the
link between cell leakage during intradiscal injection of
MSCs and the side effect, osteophyte formation, has been
suggested recently.27 Labeled MSCs were not found in NP
but within the osteophytes with endochondral ossification
signs, providing evidences that the high intradiscal pressure
may result in significant cell leakage during injection and the
misdirected MSCs may contribute to the formation of os-
teophyte via chondrogenic differentiation.27 These data raise
the concerns on undesirable side effect or complication of
MSC-based therapy in disc degeneration and suggest the
significance of developing appropriate carrier system.
Nevertheless, there is no comparative study to evaluate the
potential benefit of delivering MSCs in a microcarrier,
compared to delivering MSCs in saline alone.
We have developed a collagen microencapsulation plat-
form, which entraps living cells in a solid microsphere
made of biocompatible and biodegradable collagen nanofiber
meshwork.28 These solid microspheres have controllable size
down to 100–300mm in diameter and are injectable through
syringe needles. These microspheres exhibit viscoelastic
properties with a reduced elastic modulus of around 9 kPa,29
matching well with the elastic modulus of NP, 10kPa,30 but
differing from that of hydrogel, such as uncrosslinked hya-
luronic acid (100 Pa),7 collagen gel (132 Pa),29 and cross-
linked hyaluronic acid from commercial sources (< 200 Pa
for most and < 1.2 kPa for a few highly crosslinked).31
Moreover, these microspheres provide a 3D physiologically
relevant scaffold for the encapsulated cells to attach to the
collagen fibers via integrin-based adhesion32 and can be lo-
calized at the injection site with retained cellular viability for
at least 1 month.28 Numerous cells, including MSCs,28 em-
bryonic stem cells,33 chondrocytes,34 HEK293 cells,35 and
NP cells,36 have been microencapsulated in collagen micro-
spheres. Cells encapsulated in collagen microspheres are
able to survive, proliferate,28,33,35 and migrate.28 En-
capsulated stem cells can undergo differentiation within the
microspheres.29,33,37–39 Further, mature cells, such as chon-
drocytes34 and NP cells,36 and differentiating stem cells, such
as those toward chondrogenic29,33,37 or osteogenic38,39 line-
age, are able to remodel the template matrix by depositing
their own extracellular matrix and degrading the template
collagen matrix,29 demonstrating that the encapsulated cells
can partially exhibit their physiological functions. Owing
to these favorable properties, the collagen microsphere system
has been used as 3D culture systems,28,33,35,36,40 scaffolds for
engineered tissues,29,37–39 and miniaturized 3D microtissue
models for studies of stem cell niche such as mechanical
loading.32,41 In this study, the role of collagen microspheres as
an MSC carrier will be investigated using a rabbit disc de-
generation model.
In this study, we hypothesize that intradiscal delivery of
MSCs in solid collagen microspheres will show advantage
over delivery of MSCs in saline, by improving functional
outcomes and reducing side effect of osteophyte formation.
Specifically, we aim to induce disc degeneration in rabbits,
inject intradiscally autologous MSCs either in collagen
microspheres or in saline, and evaluate the functional out-
comes and side effect by radiographical, histological, bio-
chemical, and biomechanical methods.
Materials and Methods
All protocols involving animals were approved by the
committee for the use of Live Animals in Teaching and
Research of the University of Hong Kong. Twenty-two 3-
month-old New Zealand White rabbits were used for
autologous MSC isolation, culture, encapsulation, and sub-
sequent disc degeneration model with MSC reimplantation.
Isolation and culture of rabbit bone marrow MSCs
Under general anesthesia, 5mL of bone marrow was as-
pirated from the disinfected medial proximal tibia of rabbits
using an 18-gauge needle in a 10-mL syringe containing
2mL of heparin (5000 IU/mL). The aspirate was fraction-
ated by Ficoll density gradient centrifugation (GE Health-
care, Uppsala, Sweden) at 450 g for 30min. The buffy coats
were isolated and rinsed with phosphate-buffered solution
(PBS) twice by centrifuging at 200 g for 10min. The nu-
cleated cells were cultured in growth medium consisting of
Dulbecco’s modified Eagle’s medium high-glucose
(DMEM-HG; Gibco, Grand Island, NY), 10% fetal bovine
serum, 100U/mL penicillin, 100mg/mL streptomycin,
1.875mg/mL sodium bicarbonate, 4.766mg/mL 4-(2-hy-
droxyethyl)-1-piperazineethanesulfonic acid (HEPES), and
0.292mg/mL l-glutamine. The medium was replenished 10
days after seeding and every 4 days thereafter. When ap-
proaching confluence, adherent cells were detached by
0.25% trypsin/1mM EDTA and subcultured until P2 for
subsequent experiments.
Microencapsulation of MSCs in collagen microspheres
MSC-collagen microspheres were prepared as described
previously.28 Briefly, an aliquot of 2.5 · 105 of MSCs at P2
were encapsulated in neutralized rat tail type I collagen
solution (BD Biosciences, Bedford, MA) at a final concen-
tration of 1mg/mL in an ice bath. Droplets of 2 mL were
pipetted onto a 100-mm-diameter Petri dish (Sterlin, Stone,
United Kingdom) with UV-irradiated parafilm covering the
substratum. After incubation of 30min at 37C, the gelated
MSC-collagen microspheres were flushed with culture me-
dium into the culture dish and cultured for 3 days before
injection.
Disc degeneration model
Two months after bone marrow aspiration (5 months old),
lumbar disc degeneration was induced by needle aspiration,
modifying the procedures of previous report.42 Under gen-
eral anesthesia, the anterior surfaces of three consecutive
lumbar IVDs (L2–L3 to L4–L5) were exposed through the
retroperitoneal approach. Disc degeneration was induced by
use of a 21-gauge needle to puncture the annulus fibrosus
(AF) for a depth of 5mm before aspirating out the NP tissue
by pulling the plunger out completely at L2–L3 and L4–L5
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levels. L3–L4 was left uninjured as the internal reference.
Each rabbit was examined for the presence of NP within the
syringe needle postinjection. The wound was closed in
layers with absorbable sutures (Ethicon, Guaynabo, Puerto
Rico). The rabbits were returned to their cages after com-
plete awakening and freely mobilized.
Intradiscal injection of MSCs
One month after nucleus aspiration (6 months old), au-
tologous MSCs previously prepared were transplanted back
to the rabbits through an anterolateral approach as described
previously.42 Under general anesthesia and guided by ra-
diograph, the retroperitoneal plane was dissected and the
involved discs were exposed by separating the large psoas
muscle. By pushing a 25-gauge needle coupled to a Ha-
milton syringe for 5mm into the annulus, an aliquot of
2.5 · 105 of MSCs, either suspending in 20 mL of saline di-
rectly (MSCs in saline group), or encapsulated in collagen
microspheres suspending in same volume of saline (MSC-
collagen microsphere group), were randomly assigned and
injected to degenerative disc levels L2–L3 or L4–L5, leaving
the central L3–L4 intact as the uninjured internal reference
group. The current study compares ‘‘with’’ and ‘‘without’’
the carriers, namely, collagen microsphere using uninjured
level as an internal reference. No ‘‘vehicle control’’ was in-
cluded in this study because the formation of MSC-collagen
microsphere is a result of MSC-collagen matrix interaction
during the process of microencapsulation and hence no
‘‘MSC-free vehicle control’’ can be prepared. Moreover, no
‘‘injured but untreated’’ group was included in this study
because the potential benefits of MSC-based treatment in disc
degeneration have been well demonstrated in numerous
studies,1–20 including our own.6,12,42 Immediately after in-
jection, the injection site was sealed with Histoacryl glue
(B. Braun, Melsungen, Germany) and the wounds were
closed routinely. The rabbits were returned to their cages after
complete awakening and allowed for free movement.
Radiographic analysis
MRI monitoring at preinjection (time 0), 1, 2, 3, and 6
months postinjection was conducted as previously re-
ported.43 Briefly, sagittal T2-weighted images of lumbar
spine were taken using Siemens Magnetom Trio scanner
(3T) in Hong Kong Sanatorium and Hospital. Mixtures of
different ratios (10:0, 8:2, 6:4, 2:8, and 0:10) of deuterium
oxide/water in cryotubes were scanned along with each
rabbit as internal standard of hydration index (100%, 80%,
60%, 20%, and 0%) (Fig. 1A). A fish-oil capsule (Alaska;
Nu-Health Products Co., Walnut, CA) was also scanned
together to confirm that the fat suppression sequence was
active. Syngo FastView tools were used to view the images
(windowing at W:600 C:280) and serial images that con-
tained signal from L2/L3, L3/L4, and L4/L5 levels were
extracted analysis using the standard curve plotted using the
deuterium oxide/water internal standards. Three to five sli-
ces were analyzed for each disc. Anterior–posterior X-ray
radiographs of a rabbit spine were taken at predegeneration
( - 1), preinjection (0), 1, 2, 3, and 6 months postinjection
using cabinet X-ray system (model 43855a; Faxitron, St,
Lincolnshire, IL) with an exposure time of 18 s and pene-
tration power of 45 kV. Disc height index (DHI) of rabbit
disc was calculated as previously described.44 The change of
DHI before and after MSC injection was expressed as %DHI
(postinjection DHI/preinjection DHI) (Fig. 1B). All radio-
graphs were examined for osteophyte formation as subse-
quently described.
Sample harvesting
Rabbits were sacrificed at 6 months postinjection. Three
lumber levels of (L2/L3, L3/L4, and L4/L5) IVDs were
harvested, wrapped in PBS-soaked gauze, and stored in a
- 80C freezer until use. IVDs from 14 out of 22 rabbits
were used for biomechanical evaluation followed by bio-
chemical assessment while the rest 8 rabbits were used
for histological analysis. After discarding the surrounding
connective tissues, all specimens were examined again for
the presence of osteophytes as subsequently described.
Biomechanical test
Two days before testing, disc specimens were thawed at
4C overnight. The specimens were then potted in a 35-mm-
diameter Petri dish using two-component epoxy paste adhe-
sive (Araldite AW2104/Hardener HW 2934, HUNTSMAN).
A custom-made clamp was used to ensure that the specimens
FIG. 1. Radiographic analysis of rabbit disc degeneration.
(A) Representative magnetic resonance imaging (MRI) shows
injured rabbit lumbar discs with internal standard for cali-
bration of hydration index. (B) Representative X-ray radio-
graph showing the measurement of disc height index (DHI).
Color images available online at www.liebertpub.com/tea
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were positioned in the center of the Petri dish and were
parallel to the horizontal plane of the Petri dish. Specimens
were then kept at 4C overnight for setting of the epoxy
adhesive with PBS. On the day of testing, potted speci-
mens were tested in an ElectroForce 5200 BioDynamic
test instrument (Bose Corporation, Eden Prairie, MN) by
modifying a test protocol previously described.45 In brief,
PBS with protease inhibitors (1mg/mL Pepstatin-A, 1mM
EDTA, 1mM N-ethylmaleimide, and 1mM benzamidine)
was supplemented to the specimen containing Petri dish. The
mechanical test was divided into five stages: (1) equilibration,
(2) cyclic compression, (3) quasi-static compression, (4) fre-
quency sweep, and (5) creep. Stage 1 consisted of a 30-min
dwell at - 10N, targeting IVD stress of 0.1MPa compression
based on average rabbit IVD geometry (diameter: 10mm,
height: 5mm). It acted as the minimum stress applied on
specimens in subsequent tests. Stage 2 consisted of 20 cycles
of sinusoidal compression at 1Hz with an amplitude of
16.67N centered about - 26.67N, which approximates the
body weight of mature rabbit. Stage 3 included a slow com-
pressive ramp at 0.005N/s from - 10 to - 43.33N applied on
specimens. Stage 4 represented a dynamic mechanical anal-
ysis consisting of five cycles at five different frequencies:
0.05, 0.1, 0.5, 1, and 5Hz applied from - 10 to - 43.33N in
sinusoidal compression. Finally in stage 5, the specimens
were subjected to - 66.67N, which approximates 1.5 times of
the body weight of mature rabbit, dwell for 30min. A custom-
made MATLAB code was used to analyze data collected in
each stage to obtain relevant mechanical parameters. Dis-
placement and time values collected in stages 1 and 5 were
fitted to a stretched exponential function,46
d¼ (d1 d0)[1 e (t=s)b]
Where (d1  d0) is the equilibrium height loss, t is time,
t is a time constant, and b is a stretch constant. Force and
displacement values from the average of the 18th and 19th
cycles measured in stage 2 were used to calculate the
compressive stiffness using a linear regression. In stage 3,
quasistatic stiffness was determined by linear regression of
force–displacement data. The dynamic stiffness (K*) and
the phase angle (d) were obtained by fitting data into these
functions,47
K ¼ F0
d0
 
eid and d¼ sin1 1
2p
Z t0 þT
t0
F
dd
dt
dt
 
Where F is force, d is displacement, T is period, and t is
time. Storage stiffness was calculated as K*sind while loss
stiffness as K*cosd.
Biochemical evaluation
After the biomechanical test, the NP tissue of each IVD
specimen was dissected out. Wet weight was measured
followed by digestion in 600mL of 300mg/mL papain
(Sigma-Aldrich, St. Louis, MO) in 50mM phosphate buffer
(pH 6.5), containing 5mM l-cysteine and 5mM EDTA at
60C for 48 h.48 Glycosaminoglycan (GAG) content of NP
tissue was determined by the 1,9-dimethylmethylene blue
(DMMB) method.49 GAG concentration in specimens was
calculated by calibrating against a standard curve using
shark chondroitin sulfate as standards (Sigma-Aldrich).
Collagen content of NP tissue was determined by the hy-
droxyproline assay previously described.29 The remaining
papain digestion product was hydrolyzed in 2.6-fold volume
of 6N hydrochloric acid at 110C for 16–18 h in a hydro-
lysis tube after being flushed with nitrogen gas for 30 s. The
acid hydrolyzate was neutralized by 10N sodium hydroxide.
Trans-4-hydroxy-l-proline (Sigma-Aldrich) standards,
ranging from 0 to 10 mg/mL hydroxyproline, were prepared.
One hundred microliters of the standards and neutralized
acid hydrolysate (pH 6–7) samples were added to a 96-well
plate and incubated with 50mL of 0.05M chloramine T
solution (Sigma-Aldrich) for 20min at room temperature,
followed by 50mL of 3.15M perchloric acid (Sigma-
Aldrich) for 5min at room temperature. Fifty microliters of
20% (w/v) p-dimethylaminobenzaldehyde solution (Sigma-
Aldrich) was added and incubated for 20min at 60C for
color development. The optical densities of standards and
samples were measured at 557 nm using a microplate reader
(UVM 340; ASYS Hitech GmbH, Eugendorf, Austria).
Histological and immunohistochemical evaluation
All three IVD levels of each rabbit were fixed in 4% PBS-
buffered paraformaldehyde for 72 h, and then decalcified at
4C in Morse’s solution,50 which is a mixture of equal
volume of 45% formic acid and 20% sodium citrate, for 14
days. They were dehydrated step by step in gradient ethanol
ranging from 50% to 100%, cleared in xylene, and embed-
ded in paraffin wax. The embedded IVDs were cut into 8-
mm-thick sections and stained with hematoxylin and eosin
(H&E) and Alcian blue. Type II and type I collagens were
also detected by immunohistochemistry using mouse
primary antibodies against collagen II and collagen I (Cal-
biochem; dilution ratio 1:2000), respectively. After incu-
bation at 4C overnight, sections were incubated with goat
anti-mouse secondary antibody (Dako, Hamburg, Germany)
for 30min, followed by incubation with avidin-biotin-
peroxidase complex (Vector Laboratories, Burlingame, CA)
for 30min. Positive signal was visualized by diamino-
benzidine (DAB; Dako). Hematoxylin was used for coun-
terstaining. Histological examination on osteophyte
formation was subsequently described.
Determination of osteophyte formation
and calculation of odds ratio
Presence of osteophyte formation was collectively de-
termined by X-ray radiographical analysis, physical exam-
ination, and histological confirmation. On radiographical
evaluation, presence of signal outside the disc was regarded
as osteophytes. On physical examination, presence of tissue
outgrowth outside the disc was regarded as osteophyte. In
some IVDs, both anterolateral and anterior osteophytes or
‘‘bridging osteophytes’’26 can be found in radiography that
these osteophytes are usually larger than 2mm in diameter
and therefore are regarded as ‘‘large osteophytes.’’ While in
radiographs of other IVDs, only anterior osteophytes were
detected that these osteophytes are usually smaller than
2mm in diameter and therefore were regarded as ‘‘small
osteopytes.’’ On histological confirmation using saggital
sections of the specimens, presence of tissue outgrowth
outside AF was regarded as osteophyte formation. Positive
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Alcian blue staining and collagen type II immunopositivity
were used to define the cartilaginous nature of the out-
growth. The frequency of osteophyte formation in different
groups was obtained to construct the contingency table.
Odds ratio retrospectively measures the relative risk of
having osteophytes when MSCs are delivered in a solid
carrier (MSC-collagen microsphere) as compared with that
without such a carrier (MSCs in saline). The odds ratio is
defined as the ratio of odds of having osteophyte to having
no osteophyte among specimens with the carrier, to the odds
of having osteophyte to having no osteophyte among spec-
imens without the carrier.
Statistical analyses
All quantitative data were expressed as mean – standard
error of mean or 95% confidence interval deviation unless
otherwise specified. One-way or two-way ANOVA with
repeated measurements or Bonferroni’s post hoc tests were
used to analyze radiographic measurements, extracellular
matrix composition, and biomechanical properties. Linear
trend analysis was used to reveal the loading-frequency-
dependent change in dynamic stiffness, storage stiffness,
and loss stiffness of rabbit discs in phase 4 of the biome-
chanical test. Chi-square test was used to analyze the os-
teophyte frequency data on the association between
osteophyte formation and treatment group while odds ratio
was calculated to measure the relative risk of having os-
teophyte formation. IBM SPSS 19.0 was used to execute the
analyses, and the significance level was set at 0.05.
Results
Temporal changes of hydration index and disc height
Figure 2A showed the MRI measurement on the hydra-
tion levels of different groups at different time points. Un-
injured reference showed similar hydration index of around
40% throughout 6 months. The injured groups, injected with
MSCs in saline or MSC-collagen microspheres, rapidly re-
duced the hydration level to 23% postinjury and the re-
duction leveled off, reaching about 10% at 6 months.
General linear model with repeated measurements showed
FIG. 2. MRI and X-ray radiographic analyses of rabbit disc after mesenchymal stem cell (MSC)–based treatment. (A)
Representative T2-weighted MRI images showing the hydration signal; (B) representative X-ray images showing the disc
height and osteophyte formation (white arrow); (C) bar chart showing the MRI hydration index of disc samples in various
treatment groups at different time points; (D) bar chart showing the X-ray DHI of disc samples in various treatment groups
at different time points (n = 22) (*p < 0.05). Color images available online at www.liebertpub.com/tea
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that treatment group significantly affected the hydration
index ( p < 0.001). Bonferroni’s post hoc test showed that
both the MSCs in saline group ( p < 0.001) and the MSC-
collagen microsphere group ( p< 0.001) showed significant
difference with the uninjured reference but not between
themselves ( p = 1.000). Figure 2B showed DHI of different
groups at different time points. The uninjured reference
showed similar DHI of *105% throughout 6 months. The
MSC-collagen microsphere group better maintained the disc
height with a DHI of > 100% at 1 month postinjury, ac-
counting for > 95% of the normal disc height, and of > 90%
throughout the rest of the monitoring period, accounting for
*86% of the normal disc height. The MSCs in saline group
maintained a DHI of *85% throughout 6 months, also ac-
counting for*80% of the normal disc height. General linear
model with repeated measurements showed that treatment
group significantly affected the results ( p= 0.043) while
Bonferroni’s post hoc test showed that the difference between
the MSCs in saline group and the uninjured reference was
statistically significant ( p= 0.042). Nevertheless, the differ-
ences between the MSC-collagen microsphere group and the
uninjured reference ( p= 0.306), and that between the two
treatment groups ( p= 1.000) were insignificant.
Biomechanical performance of spinal motion segments
Table 1 summarized the mechanical parameters of the
disc specimens in all groups and all stages of assessment at 6
months postinjury. In stages 1–3 and 5 of the mechanical
analysis, no significant difference was detected among all
three groups in biomechanical parameters, including phase
angle at the same frequency, quasistatic stiffness, com-
pressive stiffness, time constant, stretch constant, and creep
height loss. In stage-4 dynamic compression analysis, Figure
3A showed the box plots of the dynamic stiffness of dif-
ferent groups under dynamic mechanical analysis at in-
creasing frequencies from 0.05 to 5Hz. The mean dynamic
stiffness in MSCs in saline group showed no increasing
trend over ascending loading frequencies while that of both
the MSC-collagen microsphere group and the uninjured
control group increased as the frequency increases. One-way
ANOVA with contrast showed that MSCs in saline group
has no increasing trend over frequency ( p = 0.214) while
both the MSC-collagen microsphere group ( p = 0.031) and
the uninjured reference group ( p = 0.012) showed significant
increasing trends as the loading frequency increased. Figure
3B showed the box plots of the storage stiffness of disc
specimens versus loading frequency in log scale in different
groups. Similarly, one-way ANOVA with contrast showed
that the storage stiffness of MSCs in saline group showed no
linear increasing trend with the log loading frequency
( p = 0.285) while the MSC-collagen microsphere group
( p = 0.014) simulated that of the uninjured reference group
( p = 0.007) by exhibiting a significant linear relationship
with log loading frequency. Figure 3C showed the box plots
of the loss stiffness in different groups. Significant linear
relationship with log loading frequency was only demon-
strated in the uninjured reference group ( p = 0.002) but not
in the MSCs in saline group ( p = 0.266) and MSC-collagen
microsphere group ( p = 0.149).
Biochemical matrix composition of NP
Figure 4 showed the extracellular matrix composition
analysis in NP tissues retrieved from the disc specimens in
different groups. The uninjured reference group showed the
highest wet weight (Fig. 4A), GAG content (Fig. 4B), and
the GAG:HYP ratio (Fig. 4D) but the lowest HYP collagen
content (Fig. 4C) comparing with the MSCs in saline and
MSC-collagen microsphere groups. The MSC-collagen mi-
crosphere group showed slightly higher wet weight and
GAG content than the MSCs in saline group. One-way
ANOVA with Bonferroni’s post hoc tests showed that the
differences between the MSCs in saline and the uninjured
Table 1. Mechanical Analyses of Spinal Motion Segments of Different Groups
Test stage Mechanical parameter Control rMSCs
rMSC-collagen
microsphere
1. Equilibrium dN - d0 (mm) 2.19 (0.42) 2.51 (0.33) 1.91 (0.34)
Time constant 623 (212) 501 (164) 502 (187)
Stretch constant 0.60 (0.08) 0.59 (0.07) 0.55 (0.07)
2. Cyclic compression Compressive stiffness (N/mm) 260.18 (21.73) 238.60 (22.62) 272.69 (34.49)
3. Quasistatic compression Quasistatic stiffness (N/mm) 91.10 (11.88) 85.07 (12.22) 82.60 (10.99)
Height loss (mm) 0.49 (0.09) 0.51 (0.08) 0.51 (0.07)
4. Dynamic compression Dynamic stiffness (N/mm)
0.05Hz 217.16 (17.65) 250.75 (30.02) 242.51 (29.17)
0.1Hz 233.05 (18.68) 225.39 (27.76) 265.10 (31.59)
0.5Hz 254.61 (22.52) 244.12 (29.44) 303.96 (35.25)
1Hz 267.62 (23.43) 262.45 (31.70) 308.04 (36.74)
5Hz 301.22 (28.25) 286.29 (36.41) 357.87 (41.65)
Phase angle ()
0.05Hz 11.25 (0.71) 11.16 (0.62) 12.78 (1.21)
0.1Hz 10.22 (0.69) 10.02 (0.61) 11.62 (1.10)
0.5Hz 10.15 (0.74) 9.46 (0.64) 10.98 (1.10)
1Hz 10.15 (0.76) 9.41 (0.67) 10.43 (1.00)
5Hz 12.56 (1.82) 13.48 (3.25) 10.81 (0.90)
5. Creep dN - d0 (mm) 0.54 (0.08) 0.46 (0.06) 0.61 (0.13)
Time constant 1499 (175) 1208 (234) 1010 (184)
Stretch constant 0.48 (0.004) 0.48 (0.03) 0.50 (0.04)
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reference as well as that between the MSC-collagen mi-
crosphere and the uninjured reference were statistically
significant (all p < 0.001) but was insignificant between
the two treatment groups ( p > 0.05). For GAG content, the
differences between the MSCs in saline group and the
uninjured reference group as well as between the MSC-
collagen microsphere group and the uninjured reference
group were statistically significant (all p £ 0.002) but were
insignificant between the two treatment groups ( p> 0.05).
For HYP content, no statistical significance was found
among all groups ( p > 0.05). For GAG:HYP ratio, one-way
ANOVA with Bonferroni’s post hoc tests revealed signifi-
cant differences between the MSCs in saline group and the
uninjured reference group ( p= 0.001) but not between the
MSC-collagen microsphere group and the uninjured refer-
ence group ( p = 0.071), as well as between the two treatment
groups ( p> 0.05).
Histological and immunohistochemical evaluation
of the disc
Figure 5 showed the morphological analysis and staining
for NP matrices, including GAGs, type I collagen, and type
II collagen. In general, the aspirated levels in both saline and
microsphere groups showed shortened disc height while that
of the uninjured reference showed no distortion of disc
height. Upon H&E staining, AF of MSC-collagen micro-
sphere group (Fig. 5C) showed regular arrangement, similar
to that in the uninjured reference (Fig. 5B), while MSCs in
saline group (Fig. 5A) showed that the inner AF invaded
through the outer AF. Alcian blue staining for GAGs
showed that the MSC-collagen microsphere group and the
uninjured reference showed similar intensity (Fig. 5E, F)
while that of the MSCs in saline group showed slightly
lower intensity (Fig. 5D). Upon type I collagen immuno-
histochemistry, all groups showed similar staining (Fig. 5K–
L) while small patches with type I collagen–immunopositive
staining were found in the center of the NP region (Fig. 5L).
These type I collagen patches were likely to be the type I
collagen microspheres injected. Type II immunohisto-
chemistry showed that AF of the normal control bulged
outward because of the intact NP with high swelling pres-
sure (Fig. 6N). On the other hand, the AF lamellae of the
saline group were pressing inward, suggesting that the
aspirated NP was not regenerated (Fig. 5M). In the MSC-
collagen microsphere group (Fig. 5O), although the NP re-
gion was not as highly swollen as that of the uninjured
reference (Fig. 5N), the AF lamellae were slightly bulging
outward, indicating that the pressure was being built
up. Moreover, there were patches of type II collagen–
immunopositive regions at the center of NP, indicating that
matrix remodeling at the type I collagen microspheres may
occur.
Association between osteophyte formation
and delivery method
Figure 6 tabulated the representative lateral X-ray radio-
graphs and gross appearance of disc specimens in different
groups. Specifically, Figure 6A showed the representative
radiographs of disc specimens with and without osteophytes.
For those with osteophytes, white arrows were used to in-
dicate the presence of osteophytes. Disc specimens were
FIG. 3. Summary of mechanical performance of rabbit
degenerative discs. (A) Box plot showing the dynamic stress
against loading frequency in rMSCs, control, and micro-
sphere groups; (B) box plot showing the storage stiffness
against loading frequency in log scale in MSCs in saline
group, uninjured reference group, and MSC-collagen micro-
sphere group; (C) box plot showing the loss stiffness against
loading frequency in log scale in MSCs in saline group, un-
injured reference group, and MSC-collagen microsphere
group (red-dotted box: frequency-dependent trend).
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categorized as no identifiable osteophyte, small (< 2mm),
and large (> 2mm) osteophytes. The number on the left
lower corner of each category was the frequency of disc
specimens in that category. Figure 6B showed the repre-
sentative images of the gross appearance of disc specimens
with and without osteophytes. The disc specimens were cut
into halves for retrieval of NP tissue for biochemical content
analysis. Large tissue outgrowths were easily identified and
were marked with asterisks while small osteophytes were
identified as thin tissues that were not easily separated from
FIG. 4. Extracellular ma-
trix composition of nucleus
pulposus (NP) tissues of dif-
ferent groups. (A) Wet
weight; (B) glycosamino-
glycan (GAG) content; (C)
HYP (marker of collagen)
content; and (D) GAG:HYP
ratio (n = 14) (*p< 0.05).
FIG. 5. Histology and immunohistochemistry of intervertebral disc (IVD) in different groups. (A–C) H&E staining;
(D–F) Alcian blue staining; ( J–L) type I collagen immunohistochemistry; (M–O) type II collagen immunohistochemistry;
(A, D, J, and M) MSCs in saline group; (B, E, K, and N) uninjured reference group; (C, F, L, and O) MSC-collagen
microsphere group. Color images available online at www.liebertpub.com/tea
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the outer AF. Figure 6C showed the contingency table of the
frequency of osteophyte formation (with different sizes)
versus different groups (uninjured reference group, MSCs in
saline group, and MSC-collagen microsphere group). In
MSCs in saline group, 19 out of 22 IVDs (86.4%) showed
osteophyte formation and most of them were large ones. In
MSC-collagen microsphere group, 12 out of 22 IVDs
(54.5%) showed osteophyte formation while the rest (10/22)
were found no osteophyte. In uninjured reference group, 9 out
of 22 IVDs (40.9%) showed osteophyte formation but most of
them were small ones. Pearson Chi-square test showed that
the treatment group variable significantly associated with the
outcome measure (osteophyte formation; p= 0.007). Fre-
quency data of osteophyte formation in the MSCs in saline
group and the MSC-collagen microsphere group were used to
calculate the odds ratio, which is the ratio of the odds of
forming to not forming osteophyte among specimens with
MSC-collagen microsphere, to the odds of forming to not
forming osteophyte among specimens with MSCs in saline
(i.e., without the carrier). This calculation requires an internal
reference group and that was the uninjured reference group.
The odds ratio calculated was 0.13, suggesting significantly
reduced odds of osteophyte formation among specimens with
MSC-collagen microsphere, as compared with that without
(i.e., MSCs in saline group).
Histological and immunohistochemical confirmation
of osteophyte formation
Figure 7 showed the representative histological and im-
munohistochemical confirmation of osteophytes. In MSCs in
saline group, large and rigid outgrowth structures (Fig. 7A)
were easily identified while smaller osteophytes were iden-
tified in the MSC-collagen microsphere group (Fig. 7C).
Osteophyte structure was not identified in the uninjured ref-
erence group (Fig. 7B). MSCs in saline group did not
maintain an organized annulus lamellae structure at the an-
terior end where the injection was made and a large fibrous
structure (green-dotted line) that continuously outgrows from
the annulus could be identified (Fig. 7D). Numerous large-
cell aggregates (asterisk) could be identified within the out-
growth, suggesting cell leakage (Fig. 7D). In MSC-collagen
microsphere group, the annulus lamellae organization was
well retained and a small patch of fibrous structure (green-
dotted line) that discontinuously outgrows from the disc was
identified (Fig. 7F). In the uninjured reference group, the
annulus was intact (Fig. 7E). The IVD and the endplate re-
gions of both the MSCs in saline group (Fig. 7G) and the
MSC-collagen microsphere group (Fig. 7I) were all GAG rich
as shown from the positive Alcian blue staining although the
uninjured reference group showed most intensive staining
(Fig. 7H). IVD in all groups showed weak immunopositivity
for type I collagen (Fig. 7J–L), while both the IVD and the
endplate of all groups showed intensive immunopositivity for
type II collagen (Fig. 7M–O). The large outgrowth in the
MSCs in saline group was largely immunopositive for type
I collagen (green-dotted line, Fig. 7J) and partially im-
munopositive for both GAGs (green-dotted line, Fig. 7G) and
type II collagen (green-dotted line, Fig. 7M), suggesting the
fibrous and cartilaginous nature of the outgrowth and con-
firming the identity of the osteophyte. The small outgrowth in
the MSC-collagen microsphere group was fibrous in nature as
shown by the weak immunopositivity for type I collagen
(green-dotted line, Fig. 7L) and negative staining for both
GAG (Fig. 7I) and type II collagen (Fig. 7O).
Discussion
MSC-collagen microsphere group showed better
dynamic mechanical behavior
Frequency-dependent changes in mechanical properties
of spinal motion segment are important parameters in
evaluating disc degeneration and emerging therapies.51
Compression stiffness in healthy human spinal motion
segment linearly increases as frequency increases in log
scale.51,52 Such frequency dependence of disc stiffness has
been demonstrated in human discs53,54 and pig discs.55 This
may be related to the stiffening effect and the fluid flow
effect, which refers to more transport of fluid and ions and
higher GAGs in central NP at high frequency as the disc is
compressed.51,56 This frequency-dependent change in dy-
namic stiffness was lost when the NP was removed by
puncture injury57,58 but the loss was prevented when in-
jecting silicon polymers with suitable mechanical properties
FIG. 6. Representative X-ray radiographs and gross ap-
pearance of IVD specimens with osteophytes of different
sizes in different groups. (A) Radiographs; (B) gross ap-
pearance (the number on the lower left corner of each pic-
ture represents the frequency of specimens in that particular
category); (C) contingency table of osteophyte formation
versus different groups (n= 22). Color images available
online at www.liebertpub.com/tea
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into the disc.59 Moreover, frequency-dependent changes in
disc dynamic stiffness have been associated with extracel-
lular matrix component changes upon protease digestion and
crosslinking treatment in rat spinal motion segments45 while
chondroitinase-ABC-induced degenerative disc was found
with lower GAG content and lower dynamic stiffness,60
both suggesting that dynamic mechanical analysis of the
disc is a sensitive parameter revealing changes in matrix
structural and compositional changes. In the current study,
the presence of the collagen matrix and the fluid effect may
produce a stiffening effect, contributing to the frequency-
dependent dynamic mechanical properties. On the other
hand, in the MSCs in saline group, the absence of collagen
microsphere carrier results in a different structure and
composition of NP, leading to distortion of the frequency
dependence of the dynamic mechanical properties.
FIG. 7. Histological and immunohistochemical confirmation ofosteophyte formation. (A–C)Gross appearancewith indication
ofosteophyteformation(red-dottedline);(D–F)hematoxylinandeosin(H&E)stainingwithindicationoftheovergrowthstructures
(red-dotted line) and large-cell aggregates (asterisks); (G–I) Alcian blue staining for GAGs with indication of the cartilaginous
outgrowth structure (red-dotted line); (J–L) immunohistochemical staining for type I collagen with indication of the fibrous
outgrowth structures (red-dotted lines); (M–O) immunohistochemical staining of type II collagen with indication of the partially
cartilaginousoutgrowth (red-dotted line); (A,D,G,J,andM)MSCsinsalinegroup; (B,E,H,K,andN)uninjured referencegroup;
(C, F, I, L, andO)MSC-collagenmicrosphere group. Color images available online at www.liebertpub.com/tea
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MSC-collagen microsphere group significantly reduced
the risk of osteophyte formation
Osteophytes are bony projections formed along joint
margins. It is a typical sign of disc degeneration.26 Recently,
osteophyte formation has been reported in all animals after
intradiscal injection of MSCs to rabbit degenerative discs27
and the presence of labeled MSCs within osteophytes with
signs of endochondral ossification further suggests that cell
leakage during intradiscal injection may be one of the
causes for osteophyte formation. The current study reports
the relative frequency of osteophyte formation in MSC-
based treatments with and without carriers, using uninjured
group as the internal reference. Osteophyte formation was
found in *40% of uninjured reference group although the
majority is extremely small ones. This might be due to the
change in mechanical environment after injuring two disc
levels, above and beneath the uninjured level, therefore
causing abnormal loading and degeneration over time. With
collagen microspheres as the cell carrier, 50% of the injured
discs showed osteophyte formation, while in MSCs in saline
group, more than 86% showed osteophyte formation and the
majority is large ones. The odds ratio measuring the relative
risk of osteophyte formation in cases that deliver MSCs in
collagen microspheres to cases that deliver MSCs in saline
was 0.13. A less than unity odds ratio demonstrates reduced
risks of osteophyte formation. One possible explanation is
that the MSC-collagen microspheres are solid structures that
are highly adhesive to tissues such that once they are de-
livered intradiscally, they can be easily localized to the disc,
preventing cell leakage and the associated osteophyte for-
mation. Nevertheless, further studies are needed to delineate
the mechanism behind the reduced risk in osteophyte for-
mation and to establish the causal relationship between cell
leakage and osteophyte formation. Our results showed the
significance of using cell carrier for intradiscal injection of
MSCs in treating disc degeneration. Nevertheless, osteophyte
formation was not completely eliminated in MSC-collagen
microsphere group, suggesting that better methods to prevent
osteophyte formation are warranted. Ongoing effort in de-
veloping an annulus plug that aims to completely block the
injection portal and hence cell leakage is underway.
Limitations of the study
One limitation of this study is that the injected cells were
not labeled and hence cell leakage could not be measured
quantitatively. When injecting MSCs in saline intradically,
backflow of liquids was observed immediately after the in-
jection while when injecting MSC-collagen microspheres,
no immediate backflow was observed. Since the study
endpoint is 6 months postoperation, traditional fluorescence
labels of cells would not work; future study on genetically
labeling MSCs is warranted. Another limitation is the
qualitative analysis of osteophyte formation. In this study,
evaluation of osteophyte formation is based on qualitative
examination of X-ray radiograph, physical inspection of the
specimens, and histological confirmation. Therefore, only
frequency data are available for analysis. To compare
groups with different delivery methods using more powerful
analyses, accurate measurement of osteophyte dimension is
necessary. MicroCT imaging with volumetric analysis
would be the ideal method to analyze the irregular-shaped
osteophytes in a quantitative manner. Second, histological,
biochemical, and mechanical evaluations of the discs before
6 months were not performed as we chose to monitor the
degeneration and the efficacy of MSC injection using two
clinically relevant, noninvasive, and nondestructive radio-
graphic parameters, namely, X-ray disc height and MRI
hydration index. As a result, any early differences in these
parameters could not be revealed. Third, the current study
used rabbit puncture injury model; similar to many other
animal models for disc degeneration, it has limited repre-
sentation of the natural etiology of disc degeneration in
human. Moreover, many species, including rabbits, retain
notochordal cells in the disc even after musculoskeletal
maturation. Knowing these inevitable limitations using in-
duced generation model in animals, further studies using
more nature-mimicking models, such as the papain-induced
degeneration model and species without notochordal cells
such as bovine, are warranted.
Conclusions
This work demonstrates the significance of using cell
carriers during intradiscal injection of MSCs in treating
rabbit IVD degeneration. Comparing with delivering MSCs
in saline, delivering MSCs in collagen microsphere carriers
to degenerative disc showed better maintenance of dynamic
mechanical performance and significant reduction in the risk
of osteophyte formation, an unwanted complication associ-
ated with annulus damage and cell leakage during intra-
discal injection.
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